The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Viral Vaccine Vectors
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Viral Vaccine Vectors.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Viral Vaccine Vectors.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Viral Vaccine Vectors are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
20. International Conference on Viral Vaccine Vectors has teamed up with the Special Journal Issue on
Viral Vaccine Vectors.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
An Exploration of the Quality of Primary Caregiving Relationships between Adolescents Orphaned through AIDS and Their Grandmothers, Based on the Narratives of Stakeholders
Mmapula Petunia Tsweleng
-
A Retrospective Cross-Sectional Study on the Prevalence and Factors Associated with Virological Non-Suppression among HIV-Positive Adult Patients on Antiretroviral Therapy in Woliso Town, Oromia, Ethiopia
Teka Haile, Behailu Hawulte, Solomon Alemayehu
-
After Schubert’s Winterreise: Contemporary Aesthetic Journeys
Maria de Fátima Lambert
-
An Analysis of the Strategies Employed to Curate, Conserve and Digitize the Timbuktu Manuscripts
F. Saptouw
-
A Case Study of the Digital Translation of the Lucy Lloyd and Wilhelm Bleek |Xam and !Kun Notebooks into The Digital Bleek and Lloyd
F. Saptouw
-
Hearing Aids Maintenance Training for Hearing-Impaired Preschool Children with the Help of Motion Graphic Tools
M. Mokhtarzadeh, M. Taheri Qomi, M. Nikafrooz, A. Atashafrooz
-
Evaluation of the Hepatitis C Virus and Classical and Modern Immunoassays Used Nowadays to Diagnose It in Tirana
Stela Papa, Klementina Puto, Migena Pllaha
-
Impact of HIV/AIDS on Food Security in Pala Sub-Location, Bondo District, Kenya
S. B. Otieno, Were Fred, E. W. Kabiru, K. Waza
-
The Role of Chemokine Family, CXCL-10 Urine as a Marker Diagnosis of Active Lung Tuberculosis in HIV/AIDS Patients
Dwitya Elvira, Raveinal Masri, Rohayat Bilmahdi
-
The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) Regions
S. Ramia, N. Melhem, K. Kreidieh
-
A Real-Time Simulation Environment for Avionics Software Development and Qualification
U. Tancredi, D. Accardo, M. Grassi, G. Fasano, A. E. Tirri, A. Vitale, N. Genito, F. Montemari, L. Garbarino
-
Factors Influencing Household Expenditure Patterns on Cereal Grains in Nasarawa State, Nigeria
E. A. Ojoko, G. B. Umbugadu
-
Computing Transition Intensity Using Time-Homogeneous Markov Jump Process: Case of South African HIV/AIDS Disposition
A. Bayaga
-
An Overview of the Risk for HIV/AIDS among Young Women in South Africa: Gender Based Violence
Shaneil Taylor
-
From Type-I to Type-II Fuzzy System Modeling for Diagnosis of Hepatitis
Shahabeddin Sotudian, M. H. Fazel Zarandi, I. B. Turksen
Conference venue information will be released soon.
HIV Vaccine Strategies
T cell-based vaccines
Adjuvants
B cell-based vaccines
Vaccine Concepts
HIV Transmission
Innate and Mucosal Immunity
Viral Vaccine Vectors
Therapeutic Vaccines and Viral Latency
Preventive HIV Vaccines
Innovations in HIV Vaccine Discovery
Emerging Clinical Trials
Challenges Facing AIDS Vaccine Development
Hepatitis C Vaccine
Hepatitis B Vaccine
Hepatitis A Vaccine
Hepatitis Vaccines Trials
Human vaccines infectious and non-infectious
Vaccines emerging and re-emerging diseases: flu, ebola, HIV and malaria
Modern technologies in vaccine discovery and development
Recent trends in attenuated vaccines
Developing next-gen conjugate vaccines
Veterinary vaaccines
Virus-like particle vaccines :applications
Advancements in vaccine development
Vaccines safety and schedule
Respiratory disease vaccines
Vaccines for child and pregnant women
Adjuvants for human/ animal vaccines—current status, problems and future prospects
Toxoid vaccines and its importance
Vaccines under research and development, major diseases
Delivery technologies
Immunology/animal models
Dna vaccines
Vaccine and retro viral diseases
Vaccines business and market analysis
Age-specific immune response to vaccination
Production, manufacturing and safety
Vaccinations and immunization practices
Mucosal vaccines
Abstracts/Full-Text Paper Submission Deadline |
|
February 13, 2025 |
Notification of Acceptance/Rejection |
|
February 27, 2025 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
October 18, 2026 |
Conference Dates |
|
November 18-19, 2026 |